Xilio Therapeutics Investors
Xilio Therapeutics is a venture capital fund based in Waltham, Massachusetts, founded in 2016 The firm specializes in investing in innovative biotechnology companies that focus on advancing cancer therapies With a significant investment scale of $117,600,000, Xilio Therapeutics aims to support the development of transformative treatments in the oncology sector The fund is committed to fostering scientific breakthroughs that can improve patient outcomes and enhance the quality of care in cancer treatment
Connections from
Founded Date:
2016
Last Funding Type:
Series C
Headquarters:
USA
Employee Number:
11-50
Industry:
FemTech
Funding Status:
IPO
Investor Type:
Venture Capital Funds
Total Funding:
233000000